311.774 Report on prescriptions for abortion-inducing drugs -- Information on
486 words·~2 min read·
/ky/311-774A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
potential reversal of effect of drugs to be included with prescription --
Complications and adverse events to be reported to Vital Statistics
Branch.
(1)Each prescription issued for an abortion-inducing drug as defined in KRS
311.7731 for which the primary indication is the induction of abortion as defined
in KRS 311.720 shall be reported on a report form provided by the cabinet
within three
(3)days after the prescription was issued. The report form shall be
signed by the qualified physician who provided the abortion-inducing drug and
transmitted to the cabinet within three
(3)days after the drug was provided.
Each report shall include at minimum the information required by KRS 213.101.
(2)Information on the potential ability of a physician to reverse the effects of
abortion-inducing drugs as defined in KRS 311.7731 for which the primary
indication is the induction of abortion, including where additional information
about this possibility may be obtained and contact information for assistance in
locating a physician who may aid in the reversal, shall be provided with each
prescription issued for an abortion-inducing drug for which the primary
indication is the induction of abortion as defined in KRS 311.720.
(3)For each abortion reported to the Vital Statistics Branch as required by KRS
213.101, the report shall also state whether any abortion complication or
adverse event as defined in KRS 311.7731 or medical treatment was known to
the provider as a result of the abortion. The report shall be completed and
signed by the physician, qualified physician, or other healthcare provider who
diagnosed or treated the complication or adverse event.
(4)The report shall include at a minimum the information required by KRS
213.101 and:
(a)Whether a complication or adverse event as defined in KRS 311.7731
occurred during the abortion procedure or while the pregnant patient was
still at the facility where the abortion was performed and the level of
intervention required to attend to the complication or adverse event:
1. Emergency medical services;
2. Stabilization on site;
3. Transport to another medical facility;
4. Urgent care follow-up; and
5. Primary care provider;
(b)The date the pregnant patient presented for diagnosis or treatment for the
complication or adverse event;
(c)Whether the complication or adverse event was previously managed by
the qualified physician who provided the abortion-inducing drug as
defined in KRS 311.7731 or a backup qualified physician;
(d)The amount billed to cover the treatment for specific complications,
including whether the treatment was billed to Medicaid, private insurance,
private pay, or other method. This should include the ICD-10 codes
reported and charges for any physician, hospital, emergency room,
prescription or other drugs, laboratory tests, and any other costs for
treatment rendered; and
(e)A list of complications, adverse events, or treatments that occurred, a list
of any emergency transfers, and any follow-up treatment provided
including whether any additional drugs were provided in order to complete
the drug-induced abortion.